Mark J Biscone

V3 Loop Truncations in HIV-1 Envelope Impart Resistance to Coreceptor Inhibitors and Enhanced Sensitivity to Neutralizing Antibodies

R. Doms, J. Hoxie, L. Su, 2007, PLoS pathogens.

Opportunities and challenges in targeting HIV entry.

R. Doms, T. Pierson, Mark J Biscone, 2002, Current opinion in pharmacology.

Functional impact of HIV coreceptor-binding site mutations.

R. Doms, J. Reeves, John L. Miamidian, 2006, Virology.

Heptad Repeat 2-Based Peptides Inhibit Avian Sarcoma and Leukosis Virus Subgroup A Infection and Identify a Fusion Intermediate

P. Bates, S. M. Amberg, J. W. Balliet, 2004, Journal of Virology.

Impact of Mutations in the Coreceptor Binding Site on Human Immunodeficiency Virus Type 1 Fusion, Infection, and Entry Inhibitor Sensitivity

R. Doms, T. Pierson, J. Reeves, 2004, Journal of Virology.

Identification and Characterization of a Potent, Selective Nonpeptide Agonist of the CC Chemokine Receptor CCR8

R. Doms, C. Martínez-A, L. Kremer, 2006, Molecular Pharmacology.

Identification and Characterization of a Potent , Selective Nonpeptide Agonist of the CC Chemokine Receptor CCR 8

R. Doms, C. Martínez-A, L. Kremer, 2005 .